STERIS plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
STERIS plc (STE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 214.84 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-08-07
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-06-30 was 214.84K shares, a 27.02% increase year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-03-31 was 0.00 shares.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 8.36K shares.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 9.56K shares, a 13.06% decline year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2026 was 187.06K shares, a 13.97% decline from fiscal 2025.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 217.43K shares, a 14.38% decline from fiscal 2024.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 253.95K shares, a 7.86% increase from fiscal 2023.
- STERIS plc share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 235.44K shares, a 17.27% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2026-06-30 | 214.84K shares 10-Q · filed 2026-08-07 | 214.84K shares derived: sum of 2 quarters · filed 2026-08-07 | 223.20K shares derived: sum of 3 quarters · filed 2026-08-07 | 232.76K shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | 8.36K shares derived: sum of 2 quarters · filed 2026-05-29 | 17.91K shares derived: sum of 3 quarters · filed 2026-05-29 | 187.06K shares 10-K · filed 2026-05-29 |
| 2025-12-31 | 8.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | 17.91K shares derived: sum of 2 quarters · filed 2026-02-06 | 187.06K shares 10-Q · filed 2026-02-06 | 187.06K shares derived: sum of 4 quarters · filed 2026-02-06 |
| 2025-09-30 | 9.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 178.70K shares 10-Q · filed 2025-11-06 | 178.70K shares derived: sum of 3 quarters · filed 2025-11-06 | 178.70K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 169.14K shares 10-Q · filed 2025-08-07 | 169.14K shares derived: sum of 2 quarters · filed 2025-08-07 | 169.14K shares derived: sum of 3 quarters · filed 2025-08-07 | 180.14K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-29 | 10.99K shares derived: sum of 3 quarters · filed 2025-05-29 | 217.43K shares 10-K · filed 2025-05-29 |
| 2024-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | 10.99K shares derived: sum of 2 quarters · filed 2025-02-07 | 217.43K shares 10-Q · filed 2025-02-07 | 217.43K shares derived: sum of 4 quarters · filed 2025-02-07 |
| 2024-09-30 | 10.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | 217.43K shares 10-Q · filed 2024-11-07 | 217.43K shares derived: sum of 3 quarters · filed 2024-11-07 | 217.43K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 206.43K shares 10-Q · filed 2024-08-08 | 206.43K shares derived: sum of 2 quarters · filed 2024-08-08 | 206.43K shares derived: sum of 3 quarters · filed 2024-08-08 | 218.92K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-29 | 12.49K shares derived: sum of 3 quarters · filed 2024-05-29 | 253.95K shares 10-K · filed 2024-05-29 |
| 2023-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | 12.49K shares derived: sum of 2 quarters · filed 2024-02-08 | 253.95K shares 10-Q · filed 2024-02-08 | 253.95K shares derived: sum of 4 quarters · filed 2024-02-08 |
| 2023-09-30 | 12.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | 253.95K shares 10-Q · filed 2023-11-07 | 253.95K shares derived: sum of 3 quarters · filed 2023-11-07 | 253.95K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 241.46K shares 10-Q · filed 2023-08-08 | 241.46K shares derived: sum of 2 quarters · filed 2023-08-08 | 241.46K shares derived: sum of 3 quarters · filed 2023-08-08 | 254.51K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | 0.00 shares derived: sum of 2 quarters · filed 2023-05-26 | 13.05K shares derived: sum of 3 quarters · filed 2023-05-26 | 235.44K shares 10-K · filed 2023-05-26 |
| 2022-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | 13.05K shares derived: sum of 2 quarters · filed 2023-02-08 | 235.44K shares 10-Q · filed 2023-02-08 | 235.44K shares derived: sum of 4 quarters · filed 2023-02-08 |
| 2022-09-30 | 13.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | 235.44K shares 10-Q · filed 2022-11-09 | 235.44K shares derived: sum of 3 quarters · filed 2022-11-09 | 305.27K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 222.38K shares 10-Q · filed 2022-08-08 | 222.38K shares derived: sum of 2 quarters · filed 2022-08-08 | 292.22K shares derived: sum of 3 quarters · filed 2022-08-08 | 306.27K shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | 69.83K shares derived: sum of 2 quarters · filed 2022-05-31 | 83.88K shares derived: sum of 3 quarters · filed 2022-05-31 | 284.57K shares 10-K · filed 2022-05-31 |
| 2021-12-31 | 69.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | 83.88K shares derived: sum of 2 quarters · filed 2022-02-09 | 284.57K shares 10-Q · filed 2022-02-09 | 284.57K shares derived: sum of 4 quarters · filed 2022-02-09 |
| 2021-09-30 | 14.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | 214.73K shares 10-Q · filed 2021-11-08 | 214.73K shares derived: sum of 3 quarters · filed 2021-11-08 | 214.73K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 200.68K shares 10-Q · filed 2021-08-09 | 200.68K shares derived: sum of 2 quarters · filed 2021-08-09 | 200.68K shares derived: sum of 3 quarters · filed 2021-08-09 | 211.26K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | 0.00 shares derived: sum of 2 quarters · filed 2021-05-28 | 10.57K shares derived: sum of 3 quarters · filed 2021-05-28 | 288.94K shares 10-K · filed 2021-05-28 |
| 2020-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | 10.57K shares derived: sum of 2 quarters · filed 2021-02-09 | 288.94K shares 10-Q · filed 2021-02-09 | 288.94K shares derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-09-30 | 10.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | 288.94K shares 10-Q · filed 2020-11-06 | 288.94K shares derived: sum of 3 quarters · filed 2021-02-09 | 288.94K shares derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-06-30 | 278.36K shares 10-Q · filed 2020-08-07 | 278.36K shares derived: sum of 2 quarters · filed 2021-02-09 | 278.36K shares derived: sum of 3 quarters · filed 2021-02-09 | 289.27K shares derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-03-31 | 0.00 shares derived: 8-K 12 month − 10-Q 9 month · filed 2021-02-09 | 0.00 shares derived: sum of 2 quarters · filed 2021-02-09 | 10.90K shares derived: sum of 3 quarters · filed 2021-02-09 | 345.14K shares 8-K · filed 2021-02-09 |
| 2019-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | 10.90K shares derived: sum of 2 quarters · filed 2020-02-10 | 345.14K shares 10-Q · filed 2020-02-10 | |
| 2019-09-30 | 10.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | 345.14K shares 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | 334.24K shares 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | 436.12K shares 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |